There is a national crisis slowing clinical research due to staffing shortages, administrative burden and current clinical trial business models. Towards creating solutions, the Society for Immunotherapy of Cancer (SITC) hosted the Crisis in Clinical Research Virtual Summit on Wednesday, Aug. 17, from 10:00 a.m.–3:30 p.m. EDT. Attendees included oncologists, administrators, the National Cancer Institute (NCI), the US Food and Drug Administration (FDA), pharmaceutical companies, contract research organizations (CRO) and other major oncology professional organizations. The results of the summit are now available as an executive summary.
